経腸栄養剤の世界市場：市場規模・シェア分析 (製品別・年齢層別・フローの種類別・用途別・エンドユーザー別)、産業需要の予測 (～2030年)

世界の経腸栄養剤市場は、2023年に57億8,180万米ドルを達成し、2024年から2030年にかけて9.7%のCAGRで成長し、2030年には109億6,370万米ドルに達すると予測されています。この市場の成長は、高齢者人口の急増と、糖尿病、がん、神経疾患、消化器疾患などの慢性疾患の急増に起因しています。

標準型製剤が業界をリード

2023年には、標準型製剤が35%以上の最大シェアを占めていました。

また、このカテゴリーは予測期間を通じて優位を維持すると推定されます。

この動向の主な要因は、標準型製剤が子供であれ大人であれ、正常な消化機能を持つ人々のために正確に処方されていることです。

小児科カテゴリーが最大の市場シェアを占める

用途別に見ると、2023年には小児科カテゴリーが業界内で最大の収入シェアを獲得しました。

また、予測期間中に9.8%のCAGRを維持すると予測されています。

この動向は、早産児の増加や子どもの慢性的な状況の発生が多いことに後押しされています。

病院カテゴリーが最大の収益シェアを占める

2023年には、病院カテゴリーが業界最大のシェアを占め、全体の60%以上を占めました。

このカテゴリーもまた、予測期間中に大きく成長すると予測されています。

主に長期療養が必要な患者を対象とした病院でのこれらの処方の利用急増が、この発展の主な推進力となっています。

北米が経腸栄養剤市場を独占

北米は2030年においても約55%のシェアで市場をリードし続けると予想されます。これは、米国でこれらの製品に関するFDAの規則が標準化され、好意的に運用されているためです。

当レポートでは、世界の経腸栄養剤の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (数量・金額ベース、2017～2030年)、種類別・用途別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

• 市場力学
  • 動向
  • 促進要因
  • 抑制要因/課題
  • 促進要因/抑制要因の影響分析
• 新型コロナウイルス感染症 (COVID-19) の影響
• ポーターのファイブフォース分析

第6章 世界市場

• 概要
• 市場規模：製品別 (2017～2030年)
• 市場収益：製品別 (2017～2030年)
• 市場規模：年齢層別 (2017～2030年)
• 市場収益：年齢層別 (2017～2030年)
• 市場規模：フローの種類別 (2017～2030年)
• 市場収益：フローの種類別 (2017～2030年)
• 市場規模：用途別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場規模：エンドユーザー別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場規模：地域別 (2017～2030年)
• 市場収益：地域別 (2017～2030年)

第7章 北米市場

• 概要
• 市場規模：製品別 (2017～2030年)
• 市場収益：製品別 (2017～2030年)
• 市場規模：年齢層別 (2017～2030年)
• 市場収益：年齢層別 (2017～2030年)
• 市場規模：フローの種類別 (2017～2030年)
• 市場収益：フローの種類別 (2017～2030年)
• 市場規模：用途別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場規模：エンドユーザー別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場規模：国別 (2017～2030年)
• 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

• 概要
• 市場規模：製品別 (2017～2030年)
• 市場収益：製品別 (2017～2030年)
• 市場規模：年齢層別 (2017～2030年)
• 市場収益：年齢層別 (2017～2030年)
• 市場規模：フローの種類別 (2017～2030年)
• 市場収益：フローの種類別 (2017～2030年)
• 市場規模：用途別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場規模：エンドユーザー別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

• 市場参入企業とその提供製品/サービスの一覧
• 主要企業の競合ベンチマーク
• 主要企業の製品ベンチマーク
• 最近の戦略展開状況

第30章 企業プロファイル

• Abbott Laboratories
• Danone S.A.
• Fresenius Kabi AG
• Nestle S.A.
• Victus Inc.
• Primus Pharmaceuticals Inc.
• Meiji Holdings Company Ltd.

第31章 付録

The enteral feeding formulas market achieved a value of USD 5,781.8 million in 2023 and is projected to grow to USD 10,963.7 million by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030. This growth of the market can be credited to the surge in the elderly populace and the surge in the occurrence of chronic diseases, like diabetes, cancer, neurological diseases, and gastrointestinal diseases.

Factors That Are Boosting Market Growth

Enteral feeding formulas are specially formulated with a specific nutrient content to provide matching for malnourished individuals or individuals who are at risk of malnutrition. They have the necessary substances like vitamins, protein, and calories that one takes to live daily.

The WHO states that nearly half of the fatalities of children under five are related to undernutrition. This startling figure is flagrant, notably in middle-income countries.

Furthermore, the rising count of early births worldwide is propelling the acceptance of enteral feeding formulas to fulfill the nutritious needs of newborns, which is projected to boost the industry over the years. Moreover, the growing count of road accidents and wounds is set to propel the development of this industry.

Globally, road traffic accidents result in the deaths of roughly 1.2 million people annually.

Additionally, individuals injured in these accidents require time to heal, during which they may experience challenges with mobility and chewing.

Due to these factors, enteral feeding formulas become essential for providing necessary nutrition to injured individuals who are unable to eat conventionally.

Standard Formulas Are Leading the Industry

In 2023, standard formulas held the largest share of, more than 35% within the enteral feeding formulas industry.

The category is also estimated to continue to the dominant throughout the projection period.

The major factor for this trend is that standard formulas are precisely formulated for people with normal digestion, whether children or adults.

Standard formulas are adaptable as they can fulfill dual drives: as enteral feeding solutions and as oral supplements.

The Largest Share in The Market Was Held by The Pediatrics Category

In 2023, the pediatrics category generated the largest income share within the industry.

During the projection period, its development is projected to continue at a CAGR of 9.8% between.

This trend is propelled by a growing count of preterm births and a high occurrence of chronic situations among children.

Hospitals Category Accounts for Largest Revenue Share

In 2023, the Hospitals category held the largest industry share, of more than 60% of the total.

This category is also projected to witness significant development during the projection period.

The surge in the utilization of these formulas in hospitals, mainly for patients needing long-term care, is a major propeller of this development.

North America Dominates Enteral Feeding Formulas Market

North America is expected to continue leading the market with a share of around 55% in 2030. This will be due to the standardized and favorable FDA rules for these products in the U.S.

The US FDA has allowed infant formula manufacturers to increase the supply of pediatric formula by giving them temporary permission for enforcement discretion.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by age category
  • 1.4.3. Market size breakdown, by flow type
  • 1.4.4. Market size breakdown, by application
  • 1.4.5. Market size breakdown, by end user
  • 1.4.6. Market size breakdown, by region
  • 1.4.7. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Volume
  • 1.5.2. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Volume, by Product (2017-2030)
• 6.3. Market Revenue, by Product (2017-2030)
• 6.4. Market Volume, by Age Category (2017-2030)
• 6.5. Market Revenue, by Age Category (2017-2030)
• 6.6. Market Volume, by Flow Type (2017-2030)
• 6.7. Market Revenue, by Flow Type (2017-2030)
• 6.8. Market Volume, by Application (2017-2030)
• 6.9. Market Revenue, by Application (2017-2030)
• 6.10. Market Volume, by End User (2017-2030)
• 6.11. Market Revenue, by End User (2017-2030)
• 6.12. Market Volume, by Region (2017-2030)
• 6.13. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Volume, by Product (2017-2030)
• 7.3. Market Revenue, by Product (2017-2030)
• 7.4. Market Volume, by Age Category (2017-2030)
• 7.5. Market Revenue, by Age Category (2017-2030)
• 7.6. Market Volume, by Flow Type (2017-2030)
• 7.7. Market Revenue, by Flow Type (2017-2030)
• 7.8. Market Volume, by Application (2017-2030)
• 7.9. Market Revenue, by Application (2017-2030)
• 7.10. Market Volume, by End User (2017-2030)
• 7.11. Market Revenue, by End User (2017-2030)
• 7.12. Market Volume, by Country (2017-2030)
• 7.13. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Volume, by Product (2017-2030)
• 8.3. Market Revenue, by Product (2017-2030)
• 8.4. Market Volume, by Age Category (2017-2030)
• 8.5. Market Revenue, by Age Category (2017-2030)
• 8.6. Market Volume, by Flow Type (2017-2030)
• 8.7. Market Revenue, by Flow Type (2017-2030)
• 8.8. Market Volume, by Application (2017-2030)
• 8.9. Market Revenue, by Application (2017-2030)
• 8.10. Market Volume, by End User (2017-2030)
• 8.11. Market Revenue, by End User (2017-2030)
• 8.12. Market Volume, by Country (2017-2030)
• 8.13. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Volume, by Product (2017-2030)
• 9.3. Market Revenue, by Product (2017-2030)
• 9.4. Market Volume, by Age Category (2017-2030)
• 9.5. Market Revenue, by Age Category (2017-2030)
• 9.6. Market Volume, by Flow Type (2017-2030)
• 9.7. Market Revenue, by Flow Type (2017-2030)
• 9.8. Market Volume, by Application (2017-2030)
• 9.9. Market Revenue, by Application (2017-2030)
• 9.10. Market Volume, by End User (2017-2030)
• 9.11. Market Revenue, by End User (2017-2030)
• 9.12. Market Volume, by Country (2017-2030)
• 9.13. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Volume, by Product (2017-2030)
• 10.3. Market Revenue, by Product (2017-2030)
• 10.4. Market Volume, by Age Category (2017-2030)
• 10.5. Market Revenue, by Age Category (2017-2030)
• 10.6. Market Volume, by Flow Type (2017-2030)
• 10.7. Market Revenue, by Flow Type (2017-2030)
• 10.8. Market Volume, by Application (2017-2030)
• 10.9. Market Revenue, by Application (2017-2030)
• 10.10. Market Volume, by End User (2017-2030)
• 10.11. Market Revenue, by End User (2017-2030)
• 10.12. Market Volume, by Country (2017-2030)
• 10.13. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Volume, by Product (2017-2030)
• 11.3. Market Revenue, by Product (2017-2030)
• 11.4. Market Volume, by Age Category (2017-2030)
• 11.5. Market Revenue, by Age Category (2017-2030)
• 11.6. Market Volume, by Flow Type (2017-2030)
• 11.7. Market Revenue, by Flow Type (2017-2030)
• 11.8. Market Volume, by Application (2017-2030)
• 11.9. Market Revenue, by Application (2017-2030)
• 11.10. Market Volume, by End User (2017-2030)
• 11.11. Market Revenue, by End User (2017-2030)
• 11.12. Market Volume, by Country (2017-2030)
• 11.13. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Volume, by Product (2017-2030)
• 12.3. Market Revenue, by Product (2017-2030)
• 12.4. Market Volume, by Age Category (2017-2030)
• 12.5. Market Revenue, by Age Category (2017-2030)
• 12.6. Market Volume, by Flow Type (2017-2030)
• 12.7. Market Revenue, by Flow Type (2017-2030)
• 12.8. Market Volume, by Application (2017-2030)
• 12.9. Market Revenue, by Application (2017-2030)
• 12.10. Market Volume, by End User (2017-2030)
• 12.11. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Volume, by Product (2017-2030)
• 13.3. Market Revenue, by Product (2017-2030)
• 13.4. Market Volume, by Age Category (2017-2030)
• 13.5. Market Revenue, by Age Category (2017-2030)
• 13.6. Market Volume, by Flow Type (2017-2030)
• 13.7. Market Revenue, by Flow Type (2017-2030)
• 13.8. Market Volume, by Application (2017-2030)
• 13.9. Market Revenue, by Application (2017-2030)
• 13.10. Market Volume, by End User (2017-2030)
• 13.11. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Volume, by Product (2017-2030)
• 14.3. Market Revenue, by Product (2017-2030)
• 14.4. Market Volume, by Age Category (2017-2030)
• 14.5. Market Revenue, by Age Category (2017-2030)
• 14.6. Market Volume, by Flow Type (2017-2030)
• 14.7. Market Revenue, by Flow Type (2017-2030)
• 14.8. Market Volume, by Application (2017-2030)
• 14.9. Market Revenue, by Application (2017-2030)
• 14.10. Market Volume, by End User (2017-2030)
• 14.11. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Volume, by Product (2017-2030)
• 15.3. Market Revenue, by Product (2017-2030)
• 15.4. Market Volume, by Age Category (2017-2030)
• 15.5. Market Revenue, by Age Category (2017-2030)
• 15.6. Market Volume, by Flow Type (2017-2030)
• 15.7. Market Revenue, by Flow Type (2017-2030)
• 15.8. Market Volume, by Application (2017-2030)
• 15.9. Market Revenue, by Application (2017-2030)
• 15.10. Market Volume, by End User (2017-2030)
• 15.11. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Volume, by Product (2017-2030)
• 16.3. Market Revenue, by Product (2017-2030)
• 16.4. Market Volume, by Age Category (2017-2030)
• 16.5. Market Revenue, by Age Category (2017-2030)
• 16.6. Market Volume, by Flow Type (2017-2030)
• 16.7. Market Revenue, by Flow Type (2017-2030)
• 16.8. Market Volume, by Application (2017-2030)
• 16.9. Market Revenue, by Application (2017-2030)
• 16.10. Market Volume, by End User (2017-2030)
• 16.11. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Volume, by Product (2017-2030)
• 17.3. Market Revenue, by Product (2017-2030)
• 17.4. Market Volume, by Age Category (2017-2030)
• 17.5. Market Revenue, by Age Category (2017-2030)
• 17.6. Market Volume, by Flow Type (2017-2030)
• 17.7. Market Revenue, by Flow Type (2017-2030)
• 17.8. Market Volume, by Application (2017-2030)
• 17.9. Market Revenue, by Application (2017-2030)
• 17.10. Market Volume, by End User (2017-2030)
• 17.11. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Volume, by Product (2017-2030)
• 18.3. Market Revenue, by Product (2017-2030)
• 18.4. Market Volume, by Age Category (2017-2030)
• 18.5. Market Revenue, by Age Category (2017-2030)
• 18.6. Market Volume, by Flow Type (2017-2030)
• 18.7. Market Revenue, by Flow Type (2017-2030)
• 18.8. Market Volume, by Application (2017-2030)
• 18.9. Market Revenue, by Application (2017-2030)
• 18.10. Market Volume, by End User (2017-2030)
• 18.11. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Volume, by Product (2017-2030)
• 19.3. Market Revenue, by Product (2017-2030)
• 19.4. Market Volume, by Age Category (2017-2030)
• 19.5. Market Revenue, by Age Category (2017-2030)
• 19.6. Market Volume, by Flow Type (2017-2030)
• 19.7. Market Revenue, by Flow Type (2017-2030)
• 19.8. Market Volume, by Application (2017-2030)
• 19.9. Market Revenue, by Application (2017-2030)
• 19.10. Market Volume, by End User (2017-2030)
• 19.11. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Volume, by Product (2017-2030)
• 20.3. Market Revenue, by Product (2017-2030)
• 20.4. Market Volume, by Age Category (2017-2030)
• 20.5. Market Revenue, by Age Category (2017-2030)
• 20.6. Market Volume, by Flow Type (2017-2030)
• 20.7. Market Revenue, by Flow Type (2017-2030)
• 20.8. Market Volume, by Application (2017-2030)
• 20.9. Market Revenue, by Application (2017-2030)
• 20.10. Market Volume, by End User (2017-2030)
• 20.11. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Volume, by Product (2017-2030)
• 21.3. Market Revenue, by Product (2017-2030)
• 21.4. Market Volume, by Age Category (2017-2030)
• 21.5. Market Revenue, by Age Category (2017-2030)
• 21.6. Market Volume, by Flow Type (2017-2030)
• 21.7. Market Revenue, by Flow Type (2017-2030)
• 21.8. Market Volume, by Application (2017-2030)
• 21.9. Market Revenue, by Application (2017-2030)
• 21.10. Market Volume, by End User (2017-2030)
• 21.11. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Volume, by Product (2017-2030)
• 22.3. Market Revenue, by Product (2017-2030)
• 22.4. Market Volume, by Age Category (2017-2030)
• 22.5. Market Revenue, by Age Category (2017-2030)
• 22.6. Market Volume, by Flow Type (2017-2030)
• 22.7. Market Revenue, by Flow Type (2017-2030)
• 22.8. Market Volume, by Application (2017-2030)
• 22.9. Market Revenue, by Application (2017-2030)
• 22.10. Market Volume, by End User (2017-2030)
• 22.11. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Volume, by Product (2017-2030)
• 23.3. Market Revenue, by Product (2017-2030)
• 23.4. Market Volume, by Age Category (2017-2030)
• 23.5. Market Revenue, by Age Category (2017-2030)
• 23.6. Market Volume, by Flow Type (2017-2030)
• 23.7. Market Revenue, by Flow Type (2017-2030)
• 23.8. Market Volume, by Application (2017-2030)
• 23.9. Market Revenue, by Application (2017-2030)
• 23.10. Market Volume, by End User (2017-2030)
• 23.11. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Volume, by Product (2017-2030)
• 24.3. Market Revenue, by Product (2017-2030)
• 24.4. Market Volume, by Age Category (2017-2030)
• 24.5. Market Revenue, by Age Category (2017-2030)
• 24.6. Market Volume, by Flow Type (2017-2030)
• 24.7. Market Revenue, by Flow Type (2017-2030)
• 24.8. Market Volume, by Application (2017-2030)
• 24.9. Market Revenue, by Application (2017-2030)
• 24.10. Market Volume, by End User (2017-2030)
• 24.11. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Volume, by Product (2017-2030)
• 25.3. Market Revenue, by Product (2017-2030)
• 25.4. Market Volume, by Age Category (2017-2030)
• 25.5. Market Revenue, by Age Category (2017-2030)
• 25.6. Market Volume, by Flow Type (2017-2030)
• 25.7. Market Revenue, by Flow Type (2017-2030)
• 25.8. Market Volume, by Application (2017-2030)
• 25.9. Market Revenue, by Application (2017-2030)
• 25.10. Market Volume, by End User (2017-2030)
• 25.11. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Volume, by Product (2017-2030)
• 26.3. Market Revenue, by Product (2017-2030)
• 26.4. Market Volume, by Age Category (2017-2030)
• 26.5. Market Revenue, by Age Category (2017-2030)
• 26.6. Market Volume, by Flow Type (2017-2030)
• 26.7. Market Revenue, by Flow Type (2017-2030)
• 26.8. Market Volume, by Application (2017-2030)
• 26.9. Market Revenue, by Application (2017-2030)
• 26.10. Market Volume, by End User (2017-2030)
• 26.11. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Volume, by Product (2017-2030)
• 27.3. Market Revenue, by Product (2017-2030)
• 27.4. Market Volume, by Age Category (2017-2030)
• 27.5. Market Revenue, by Age Category (2017-2030)
• 27.6. Market Volume, by Flow Type (2017-2030)
• 27.7. Market Revenue, by Flow Type (2017-2030)
• 27.8. Market Volume, by Application (2017-2030)
• 27.9. Market Revenue, by Application (2017-2030)
• 27.10. Market Volume, by End User (2017-2030)
• 27.11. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Volume, by Product (2017-2030)
• 28.3. Market Revenue, by Product (2017-2030)
• 28.4. Market Volume, by Age Category (2017-2030)
• 28.5. Market Revenue, by Age Category (2017-2030)
• 28.6. Market Volume, by Flow Type (2017-2030)
• 28.7. Market Revenue, by Flow Type (2017-2030)
• 28.8. Market Volume, by Application (2017-2030)
• 28.9. Market Revenue, by Application (2017-2030)
• 28.10. Market Volume, by End User (2017-2030)
• 28.11. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Abbott Laboratories
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Danone S.A.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Fresenius Kabi AG
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Nestle S.A.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Victus Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Primus Pharmaceuticals Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Meiji Holdings Company Ltd.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports